| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/26/2009 | US20090081645 Method of assuming drug sensitivity to cdk4 inhibitor |
| 03/26/2009 | US20090081644 Ligation amplification |
| 03/26/2009 | US20090081643 Methods for evaluating ribonucleotide sequences |
| 03/26/2009 | US20090081642 Novel apoptosis gene EI24, compositions, and methods of use |
| 03/26/2009 | US20090081641 Methods and systems for treating disease |
| 03/26/2009 | US20090081640 Methods of using miRNA for detection of in vivo cell death |
| 03/26/2009 | US20090081639 Assay for sensitivity to chemotherapeutic agents |
| 03/26/2009 | US20090081638 Immobilisation of Antigenic Carbohydrates to Support Detection of Pathogenic Microorganisms |
| 03/26/2009 | US20090081637 Screening nucleic acid comprising sequence that encodes reverse transciptase domain of DNA polymerase for adefovir-resistant mutations; use in vaccine development |
| 03/26/2009 | US20090081636 Pharmaceutical compositions for and methods of inhibiting HCV replication |
| 03/26/2009 | US20090081635 Modified heparinase iii and methods of sequencing therewith |
| 03/26/2009 | US20090081634 Fluorescent and saccharidic substrates, their process of preparation and their use |
| 03/26/2009 | US20090081633 Seed testing method and apparatus |
| 03/26/2009 | US20090081252 Decreasing potential iatrogenic risks associated with influenza vaccines |
| 03/26/2009 | US20090081245 Assays for development of boris mutants suitable for vaccine development and small molecule inhibitors of wild-type boris |
| 03/26/2009 | US20090081243 Agents and methods for diagnosing stress |
| 03/26/2009 | US20090081237 Prognostic, diagnostic, and cancer therapeutic uses of FANCI and FANCI modulating agents |
| 03/26/2009 | US20090081229 Anti-pro87299 antibodies |
| 03/26/2009 | US20090081226 Soluble HLA-E Molecules And Their Use For Diagnosing And Treating Pathologies |
| 03/26/2009 | US20090081222 Novel splice variants of the egf receptor |
| 03/26/2009 | US20090081215 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081214 Genetic products differentially expressed in tumors and use thereof |
| 03/26/2009 | US20090081209 Methods of therapy and diagnosis using targeting of cells that express killer cell immunoglobulin-like receptor-like proteins |
| 03/26/2009 | US20090081197 Methods for Selection of Melanocortin Receptor-Specific Agents for Treatment of Obesity |
| 03/26/2009 | US20090081195 Inhibitors of Ste20-like Kinase (SLK) and Methods of Modulating Cell Cycle Progression and Cell Motility |
| 03/26/2009 | US20090081192 Methods of screening for compounds having anti-inflammatory activity |
| 03/26/2009 | US20090081189 Process for in vitro differentiation of neuronal stem cells or of cells derived from neuronal stem cells |
| 03/26/2009 | US20090081173 Methods and compositions involving bacteriophage isolates |
| 03/26/2009 | US20090081170 Cardiac progenitor cells |
| 03/26/2009 | US20090081159 Compositions and methods for detecting and treating ophthalmic disorders |
| 03/26/2009 | US20090081129 Bioluminescent Endoscopy Methods And Compounds |
| 03/26/2009 | US20090081125 Angiogenetic Agent Containing Adrenomedulin as the Active Ingredient |
| 03/26/2009 | US20090081124 Virus coat protein/receptor chimeras and methods of use |
| 03/26/2009 | US20090078586 Small Volume In Vitro Analyte Sensor |
| 03/26/2009 | US20090078574 Charge tags and the separation of nucleic acid molecules |
| 03/26/2009 | CA2803927A1 Microfluidic device and method for fluid clotting time determination |
| 03/26/2009 | CA2711818A1 Method of reducing the effects of cytostatic drugs on bone marrow derived cells, and methods of screening |
| 03/26/2009 | CA2705306A1 Neoepitope detection of disease using protein arrays |
| 03/26/2009 | CA2700265A1 Compositions and methods for altering the morphology of plants |
| 03/26/2009 | CA2700200A1 Identification of novel pathways for drug development for lung disease |
| 03/26/2009 | CA2700125A1 Detection of saliva proteins modulated secondary to ductal carcinoma in situ of the breast |
| 03/26/2009 | CA2700082A1 Nucleobase characterisation |
| 03/26/2009 | CA2699958A1 Identification and isolation of fetal cells and nucleic acid |
| 03/26/2009 | CA2699860A1 Cardiomyocyte-like cell clusters derived from hbs cells |
| 03/26/2009 | CA2699859A1 Compositions and methods for the identification of inhibitors of retroviral infection |
| 03/26/2009 | CA2699856A1 Improved methylation detection |
| 03/26/2009 | CA2699853A1 Improved detection of mage-a expression |
| 03/26/2009 | CA2699828A1 Method for measuring substrate concentration and device for the same |
| 03/26/2009 | CA2699760A1 Compositions and methods for diagnosis and treatment of type 2 diabetes |
| 03/26/2009 | CA2699606A1 Novel markers for bladder cancer detection |
| 03/26/2009 | CA2699569A1 Hydrogel labeled primer extension method for microarrays |
| 03/26/2009 | CA2699518A1 Supramolecular nanostamping printing device |
| 03/26/2009 | CA2699315A1 Self-actuating signal producing detection devices and methods |
| 03/26/2009 | CA2698397A1 Method of conferring a protective immune response to norovirus |
| 03/26/2009 | CA2698390A1 A rapid and sensitive method for detection of biological targets |
| 03/26/2009 | CA2697640A1 Tools and methods for genetic tests using next generation sequencing |
| 03/26/2009 | CA2697532A1 Method of amplifying nucleic acid |
| 03/26/2009 | CA2694494A1 Hpiv-2 variants and medical applications thereof |
| 03/26/2009 | CA2688558A1 Biomarker combinations for colorectal cancer |
| 03/26/2009 | CA2670019A1 Methods, systems, and compositions for cancer diagnosis |
| 03/25/2009 | EP2040187A1 Gene information processing apparatus and gene information display apparatus |
| 03/25/2009 | EP2040078A1 Method for quantifying phosphokinase activity on proteins |
| 03/25/2009 | EP2040068A2 Nucleic acid detection sensor |
| 03/25/2009 | EP2040065A1 Method and apparatus for measuring liquid sample |
| 03/25/2009 | EP2039782A2 Method and apparatus for judging the presence or absence of cancer cell |
| 03/25/2009 | EP2039781A1 Displacement assay for detecting nucleic acid oligomer hybridisation events |
| 03/25/2009 | EP2039780A1 Single-readout multiplexing of metagenes |
| 03/25/2009 | EP2039779A1 Screening method |
| 03/25/2009 | EP2039778A2 Article and method for detection of enterotoxigenic staphylococci |
| 03/25/2009 | EP2039769A2 Antimicrobial peptides and methods of use |
| 03/25/2009 | EP2039765A1 Method for determination of 1,5-anhydroglucitol, and reagent composition for determination of 1,5-anhydroglucitol |
| 03/25/2009 | EP2039762A2 Nitralases |
| 03/25/2009 | EP2039755A2 Device and methods for detecting microorganisms |
| 03/25/2009 | EP2039367A1 Prophylactic/therapeutic agent for neurodegenerative disease |
| 03/25/2009 | EP2038651A2 An in vitro method of detecting and/or diagnosing cancer using uv light based dna image cytometry |
| 03/25/2009 | EP2038432A2 A method for detecting nucleic acids |
| 03/25/2009 | EP2038431A1 Method for determining preeclampsia risk |
| 03/25/2009 | EP2038430A1 Toll like receptor 4 dysfunction and the biological applications thereof |
| 03/25/2009 | EP2038428A1 Methods for detection of a target nucleic acid by forming a cleavage structure using a reverse transcriptase |
| 03/25/2009 | EP2038427A2 Single-molecule pcr on microparticles in water-in-oil emulsions |
| 03/25/2009 | EP2038425A1 High throughput physical mapping using aflp |
| 03/25/2009 | EP2038416A1 Nitrogen limitation adaptibility gene and protein and modulation thereof |
| 03/25/2009 | EP2038415A1 Dph2 gene deletion mutant and uses thereof |
| 03/25/2009 | EP2038409A2 Novel human acidic mammalian chitinase and use thereof |
| 03/25/2009 | EP2037948A2 Detecting and treating dementia |
| 03/25/2009 | EP2037945A2 Permeability of blood-brain barrier |
| 03/25/2009 | EP1920239A4 Detection and measurement of blood-feeding activity |
| 03/25/2009 | EP1910549A4 Analyzing messenger rna and micro rna in the same reaction mixture |
| 03/25/2009 | EP1899725A4 Nucleic acid biosensor with photoelectrochemical amplification |
| 03/25/2009 | EP1888775A4 Method for measuring effectively the activity of cytotoxic t lymphocyte in human and out-bred animals |
| 03/25/2009 | EP1859050A4 A method for the detection of chromosomal aneuploidies |
| 03/25/2009 | EP1856503A4 Dual path immunoassay device |
| 03/25/2009 | EP1815022A4 Method of determining a cellular response to a biological agent |
| 03/25/2009 | EP1766401B1 Method for the simple and rapid detection of cells and biomolecules by means of paramagnetic particles |
| 03/25/2009 | EP1711808A4 Method for measurement of immature granulocytes |
| 03/25/2009 | EP1641810A4 Prediction of likelihood of cancer recurrence |
| 03/25/2009 | EP1633888B1 Means and method for the detection of target nucleotide sequences using ligation assays with improved oligonucleotide probe pairs |
| 03/25/2009 | EP1633854B1 Gene expression profiling in primary ovarian serous papillary tumors and normal ovarian epithelium |
| 03/25/2009 | EP1615942A4 Polymerase inhibitor and method of using same |
| 03/25/2009 | EP1551627A4 Method and composition for forming a protective coating on an assay substrate and substrate produced by the same |